We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$13.4B
AUM Growth
+$5.98B
Cap. Flow
+$4.58B
Cap. Flow %
34.18%
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$51.4M
2
LOW icon
Lowe's Companies
LOW
+$45.3M
3
CVS icon
CVS Health
CVS
+$37.3M
4
LLY icon
Eli Lilly
LLY
+$32.7M
5
SO icon
Southern Company
SO
+$30.6M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Consumer Discretionary 11.59%
3 Healthcare 8.66%
4 Financials 6.8%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPR
3351
DELISTED
Express, Inc.
EXPR
-17,702
Closed -$216K
MARK
3352
DELISTED
Remark Holdings, Inc.
MARK
-5,732
Closed -$67K
DMK
3353
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-315
Closed -$17K
SRT
3354
DELISTED
Startek Inc.
SRT
-21,571
Closed -$113K
RPT
3355
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-45,968
Closed -$250K
VRTV
3356
DELISTED
VERITIV CORPORATION
VRTV
-23,157
Closed -$293K
ARGO
3357
DELISTED
Argo Group International Holdings, Ltd.
ARGO
-13,218
Closed -$455K
ICPT
3358
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-18,300
Closed -$759K
AVID
3359
DELISTED
Avid Technology Inc
AVID
-28,266
Closed -$242K
SCPL
3360
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
-59,342
Closed -$963K
RVLP
3361
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-58,102
Closed -$314K
CIR
3362
DELISTED
CIRCOR International, Inc
CIR
-16,335
Closed -$447K
EMAN
3363
DELISTED
eMagin Corporation
EMAN
-76,782
Closed -$98K
RAD
3364
DELISTED
Rite Aid Corporation
RAD
-28,562
Closed -$271K
SDC
3365
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
-90,560
Closed -$1.06M
PRTK
3366
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-31,187
Closed -$169K
PIAI.U
3367
DELISTED
Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share
PIAI.U
-300,000
Closed -$3.01M
FRG
3368
DELISTED
Franchise Group, Inc.
FRG
-24,770
Closed -$628K
NMTR
3369
DELISTED
9 Meters Biopharma
NMTR
-6,070
Closed -$99K
RUTH
3370
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-27,838
Closed -$308K
MNTV
3371
DELISTED
Momentive Global Inc. Common Stock
MNTV
-18,200
Closed -$402K
SEAC
3372
DELISTED
Seachange International Inc
SEAC
-7,976
Closed -$139K
ALR
3373
DELISTED
AlerisLife Inc
ALR
-23,040
Closed -$117K
CNCE
3374
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-20,393
Closed -$200K
ALBO
3375
DELISTED
Albireo Pharma Inc
ALBO
-9,448
Closed -$315K

Similar funds

Squarepoint's Q4 2020 Portfolio in Review

As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Squarepoint deployed $4.58B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.

  • Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
  • Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
  • Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
  • Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
  • Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
  • Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.